Glucose clinical diagnostics

The use of ELISA is broad and it finds applications in many biological laboratories over the last 30 years many tests have been developed and vahdated in different domains such as clinical diagnostics, pharmaceutical research, industrial control or food and feed analytics for instance. Our work has been to redesign the standard ELISA test to fit in a microfluidic system with disposable electrochemical chips. Many applications are foreseen since the biochemical reagents are directly amenable from a conventional microtitre plate to our microfluidic system. For instance, in the last 5 years, we have reported previous works with this concept of microchannel ELISA for the detection of thromboembolic event marker (D-Dimer) [4], hormones (TSH) [18], or vitamin (folic acid) [24], It is expected that similar technical developments in the future may broaden the use of electroanalytical chemistry in the field of clinical tests as has been the case for glucose monitoring. This work also contributes to the novel analytical trend to reduce the volume and time consumption in analytical labs using lab-on-a-chip devices. Not only can an electrophoretic-driven system benefit from the miniaturisation but also affinity assays and in particularly immunoassays with electrochemical detection. 

Srinivasan V, Pamula VK, Fair RB (2004) Droplet-based microfluidic lab-on-a-chip for glucose detection. Anal Chim Acta 507 145-150 Srinivasan V, Pamula VK, Fair RB (2004) An integrated digital microfluidic lab-on-a-chip for clinical diagnostics on human physiological fluids. Lab Chip 4 310-315... 

Clinical/diagnostics For clinical diagnostics, a lot of sensors have been developed for medical diagnosis of various analytes in blood samples like glucose, cholesterol, urea, lactate, uric acid, creatinine, both qualitatively and quantitatively. To detect... 

Frost, M.C., Wolf, A.K., Meyerhoff, M.E., 2013. In vivo sensors for continuous monitoring of blood gases, glucose, and lactate biocompatibihty challenges and potential solutions. Detection Challenges in Clinical Diagnostics 2, 129. 

Clinical utility takes the concept a step further and shows that the patient s medical outcome is favorably influenced by knowledge of the diagnostic test. An example would be that the tight insulin control that is only possible with frequent home blood glucose monitoring has a positive impact on delay of complications of diabetes. FDA does not require that a demonstration of clinical utility be performed in support of submissions but does... 

In the majority of cases, a UCD can be distinguished from other inborn errors of metabolism by routinely available clinical chemistry tests such as blood gases, acid/base balance, plasma glucose, ammonium, or lactate. Urea production, and hence serum urea nitrogen, is decreased in UCDs. Respiratory alkalosis has few causes and is an important diagnostic clue of hyperammonemia that should trigger measurement of plasma ammonium. 

---